Walden reported positive topline data from a Phase I clinical trial of its lead ...
The two companies will develop neuroplastogens for psychiatric disorders as psyc...
Cytokinetics plans to file for approval in both the US and Europe for its hypert...
Dandelion Health’s database can be used as a tool for sponsors to decide which i...
Sanofi has announced a significant investment exceeding €1bn ($1.07bn) to expand...
The UK Government is set to revise legislation, allowing professionals to supply...
Pint Pharma has announced that COFEPRIS in Mexico has approved ORLADEYO (berotra...
The UK NHS has introduced Pfizer's tafamidis for transthyretin amyloidosis cardi...
The approval was supported by the TRIDENT-1 trial studying Augtyro in TKI-naïve ...
Almost 12 months after the South American Summit, advancing pharma trade and rai...
Shionogi has concluded an exclusive global licence agreement for Maze Therapeuti...
Tabuk obatined rights to commercialise Formosacs l'obetasol propionate ophthalmi...
GlobalData examines four of the key trends affecting contract research organizat...
Attovia Therapeutics has secured $105m in a Series B financing round to expedite...
Novo Nordisk has entered into a deal with Flagship Pioneering and Metaphore Biot...
Sanofi has signed a $1.2bn licensing agreement with Novavax to co-commercialise ...
